Mirum Pharmaceuticals, Inc.MIRMNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-87.61M
Near historical average
Average (6y)
$-94.76M
Historical baseline
Range
High:$-2.92M
Low:$-173.41M
CAGR
+76.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-87.61M | +19.7% |
| 2023 | $-109.15M | +16.8% |
| 2022 | $-131.22M | +24.3% |
| 2021 | $-173.41M | -66.3% |
| 2020 | $-104.30M | -90.5% |
| 2019 | $-54.74M | -1777.3% |
| 2018 | $-2.92M | - |